2007
DOI: 10.1016/j.tox.2007.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
96
0
4

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 155 publications
(106 citation statements)
references
References 31 publications
6
96
0
4
Order By: Relevance
“…Bull. to reduce the CYP1A2 activity in human tissue. [14][15][16] However, the results of the caffeine test in the present study showed that the 90% CI ranges of the phenotypic indices of CYP1A2, NAT2 and XO were within the bioequivalence range defined by the Food and Drug Administration (FDA) ( Table 1 and Fig. 1).…”
Section: Discussionmentioning
confidence: 45%
See 2 more Smart Citations
“…Bull. to reduce the CYP1A2 activity in human tissue. [14][15][16] However, the results of the caffeine test in the present study showed that the 90% CI ranges of the phenotypic indices of CYP1A2, NAT2 and XO were within the bioequivalence range defined by the Food and Drug Administration (FDA) ( Table 1 and Fig. 1).…”
Section: Discussionmentioning
confidence: 45%
“…[14][15][16][17][18][19] Safrole, isosafrole and liquiritigenin (essential constituents of Japanese Angelica root or Glycyrrhiza, which are components of YKS) have been shown Biol. Pharm.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Inhibition of BFCOD BFCOD activity is used as a marker of CYP3A in humans (Renwick et al, 2000;Appiah-Opong et al, 2007) and pigs (Nannelli et al, 2008), although some studies have used BFC as a marker of CYP1A/2B in humans and rats (Price et al, 2008). In fish, BFC is believed to be the specific substrate for CYP3A (Christen et al, 2009).…”
Section: Inhibition Patternmentioning
confidence: 99%
“…4,5 The use of this kind of molecules with differential specificities and the effect of these molecules on directed enzymatic reactions has been a useful tool to identify enzymes related with the biotransformation of certain xenobiotics, endogenous metabolites and drugs. [6][7][8][9] A widely used strategy to identify an enzyme involved in a metabolic pathway is to correlate the prototype enzymatic activity with the target substrate molecule activity. [10][11][12][13] In the same way, quantification of enzyme expression by immunoblot and correlation of the amount of protein expressed with the enzyme activity of interest has been used to characterize enzymatic activities.…”
Section: Introductionmentioning
confidence: 99%